Physician

Ada I. Arias, M.D.

According to 2025 Medicare claims, Ada Arias, M.D. (NPI: 1306848171) practices critical care (intensivists) in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ADA I ARIAS MD SC (NPI: 1023017480; TIN: 364199256) and primary practice location at 60622-3043.

Arias' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 375 traditional Medicare patients, billed 2,404 HCPCS/CPT codes, and received $170,418 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 4,119 prescription claims across 386 beneficiaries totaling $1,141,228 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,500 claims. Open Payments data shows 15 records totaling $346. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $409,063 to $170,418. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $44,549 to $142,138.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	684	4,654	$409,063
2016	724	4,682	$427,111
2017	673	4,271	$399,953
2018	692	4,452	$405,900
2019	612	4,086	$366,881
2020	551	4,202	$358,916
2021	522	3,483	$313,308
2022	462	3,232	$266,113
2023	458	3,119	$280,224
2024	375	2,404	$170,418

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	292	4,338	$522,259
2016	339	5,262	$796,987
2017	385	4,905	$1,127,456
2018	398	4,452	$1,228,073
2019	383	4,189	$1,380,602
2020	327	3,415	$1,094,145
2021	312	2,710	$871,682
2022	336	2,621	$985,668
2023	372	3,466	$1,048,704
2024	386	4,119	$1,141,228

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	394	1,251	$44,977
2016	532	1,668	$58,835
2017	581	1,918	$55,724
2018	715	2,349	$114,360
2019	774	2,582	$137,992
2020	671	2,430	$153,735
2021	655	2,029	$106,724
2022	586	1,946	$106,744
2023	456	1,644	$134,827
2024	429	1,500	$142,717

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	112	145	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	489	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	157	1,102	$59
94726	Test to determine lung volumes using sensors	51	51	$8
94060	Test to measure expiratory airflow and volume changes before and after medication administration	51	51	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	25	750	$320,941
Breo Ellipta	Fluticasone/Vilanterol	363	12,540	$161,723
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	221	7,740	$155,167
Xolair	Omalizumab	41	1,204	$94,791
Spiriva Respimat	Tiotropium Bromide	131	4,290	$74,161

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	13	64	$63,693
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	29	$26,157
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	31	231	$17,040
E1392	Portable oxygen concentrator, rental	Y	17	136	$4,696
E0601	Continuous positive airway pressure (cpap) device	Y	23	122	$3,866

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$346	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ada I. Arias, M.D.?

Tedicare shows public-source Medicare data for Ada I. Arias, M.D. (NPI 1306848171), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ada I. Arias, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ada I. Arias, M.D.?

Ada I. Arias, M.D. is linked to ADA I ARIAS MD SC (billing NPI 1023017480) in the available physician profile data.

Does Ada I. Arias, M.D. have Open Payments data?

Ada I. Arias, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.